Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lacroix

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal (Canadian Dental Association)|July 1, 1995
[Herpesvirus infection: from the primary oral lesion to recurrent herpes]I Lacroix, C Mascrès
Bioorganic & Medicinal Chemistry|January 13, 2000
Microbial models of drug metabolism: microbial transformations of Trimegestone (RU27987), a 3-keto-delta(4,9(10))-19-norsteroid drugI Lacroix, J Biton, R Azerad
Bioorganic & Medicinal Chemistry|July 1, 1997
Microbial biotransformations of a synthetic immunomodulating agent, HR325I Lacroix, J Biton, R Azerad
Comparative Biochemistry and Physiology. Part A, Physiology|November 1, 1994
Use of monoclonal antibodies for identification of growth-controlling neuropeptides in the mussel Mytilus edulis (Mollusca:Bivalvia)K Kellner-Cousin, V Boulo, I Lacroix, et al.
Lancet (London, England)|November 30, 2000
Prescription of drugs during pregnancy in FranceI Lacroix, C Damase-Michel, M Lapeyre-Mestre, et al.
Annales De Biologie Clinique|July 1, 1997
[Pregnancy and perinatality: biological follow-up]Y Badonnel, M Berland, I Lacroix, et al.
Fundamental & Clinical Pharmacology|April 7, 2004
Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary careI Lacroix, M Lapeyre-Mestre, H Bagheri, et al.
Biochemical Pharmacology|July 21, 1999
Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathwayL Petit, I Lacroix, P de Coppet, et al.
Gynecologie, Obstetrique & Fertilite|September 20, 2011
[Drugs in pregnancy: study in the EFEMERIS database (2004 to 2008)]C Hurault-Delarue, I Lacroix, S Vidal, et al.
Therapie|July 31, 2001
[Follow-up of 'medications and pregnancy' at the Midi-Pyrenees Pharmacovigilance Center']T Lemoine, I Lacroix, M Lapeyre-Mestre, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal (Canadian Dental Association)|July 1, 1995
[Herpesvirus infection: from the primary oral lesion to recurrent herpes]I Lacroix, C Mascrès
Bioorganic & Medicinal Chemistry|January 13, 2000
Microbial models of drug metabolism: microbial transformations of Trimegestone (RU27987), a 3-keto-delta(4,9(10))-19-norsteroid drugI Lacroix, J Biton, R Azerad
Bioorganic & Medicinal Chemistry|July 1, 1997
Microbial biotransformations of a synthetic immunomodulating agent, HR325I Lacroix, J Biton, R Azerad
Comparative Biochemistry and Physiology. Part A, Physiology|November 1, 1994
Use of monoclonal antibodies for identification of growth-controlling neuropeptides in the mussel Mytilus edulis (Mollusca:Bivalvia)K Kellner-Cousin, V Boulo, I Lacroix, et al.
Lancet (London, England)|November 30, 2000
Prescription of drugs during pregnancy in FranceI Lacroix, C Damase-Michel, M Lapeyre-Mestre, et al.
Annales De Biologie Clinique|July 1, 1997
[Pregnancy and perinatality: biological follow-up]Y Badonnel, M Berland, I Lacroix, et al.
Fundamental & Clinical Pharmacology|April 7, 2004
Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary careI Lacroix, M Lapeyre-Mestre, H Bagheri, et al.
Biochemical Pharmacology|July 21, 1999
Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathwayL Petit, I Lacroix, P de Coppet, et al.
Gynecologie, Obstetrique & Fertilite|September 20, 2011
[Drugs in pregnancy: study in the EFEMERIS database (2004 to 2008)]C Hurault-Delarue, I Lacroix, S Vidal, et al.
Therapie|July 31, 2001
[Follow-up of 'medications and pregnancy' at the Midi-Pyrenees Pharmacovigilance Center']T Lemoine, I Lacroix, M Lapeyre-Mestre, et al.
Pageof 3